“…These procedures reduce IOP by different mechanisms: 1) ablate or bypass the trabecular meshwork (TM) using instruments such as the Trabectome (Neomedix Corporation, Tustin, CA, USA) [9][10][11], iStent (Glaukos Corp., Laguna Hills, CA, USA) [12], or the Hydrus mini-stent (Ivantis Inc., Irvine, CA, USA) [13]; 2) establish a new route for suprachoroidal drainage (CyPass Micro-Stent; Transcend Medical, Menlo Park, CA, USA [14]; 3) reduce the production of aqueous humor [15]; or 4) create a subconjunctival filtration route [16].…”